SciNeuro Pharmaceuticals
PrivateLast Round
VC Round
Dec 4, 2025
Total Funding Raised
$153M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SciNeuro Pharmaceuticals is a biotechnology company that develops innovative drugs and therapies for the treatment of central nervous system and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SciNeuro Pharmaceuticals Comparables
Compare SciNeuro Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuron23 | 83% | |
| Korsana Biosciences | 82% | |
| Alector | 76% | |
SciNeuro Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 4, 2025 | ||||
| Series B | Dec 4, 2025 | ||||
| Series A | Dec 8, 2020 |
SciNeuro Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boyu Capital | Series A |
| Zoo Capital | Series A |
| TF Capital | Series A |
| ARCH Venture Partners | VC Round, Series B, Series A |
| ARCH Venture Partners | Series B, Series A |
| Sequoia Capital | Series A |
| The Michael J. Fox Foundation for Parkinson's Research | VC Round, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
Developing a new de novo amyloid beta antibody program in collaboration with Novartis.
- Jan 12, 2026
Exclusive worldwide licensing deal with Novartis Pharma AG for Alzheimer's drug.
SciNeuro Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SciNeuro Pharmaceuticals's valuation, stock price, and market status.